ATURGYL 0.05 %, solution as a nasal spray bottle, 15 ml
Active ingredients: Oxymetazoline hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for sprayingbottle, 15 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATURGYL 0,05 POUR CENT, solution pour pulvérisation nasale
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 1 flacon(s) polyéthylène de 15 ml
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63581266CIP73008456CIP133400930084564Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'OXYMÉTAZOLINEsolution | 0,050 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.